Gilead’s Kite Pharma acquires Interius BioTherapeutics for $350 million Purchase is latest move in race to develop simpler, safer, and more scalable cell therapies

https://www.statnews.com/2025/08/21/gilead-kite-pharma-acquires-interius-biotherapeutics/